| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |